Pacer Nasdaq International Patent Leaders ETF (PATN) Performance
PATN total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +22.9% since Dec 31, 2025
- 1 year
- +24.5% total return
- Since first price
- +69.1% since 2024
PATN trailing returns vs SPY, QQQ, AGG
| Period | PATN total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | −8.2% | −8.2% | −1.0% | −5.0% | +0.9% |
| 3 months | −4.3% | −4.4% | +3.2% | +1.9% | −0.4% |
| 6 months | +4.9% | +4.7% | +7.8% | +8.4% | −1.5% |
| YTD | +22.9% | +22.6% | +12.3% | +15.1% | −1.0% |
| 1 year | +24.5% | +21.7% | +14.4% | +15.9% | −1.1% |
| Since inceptionSep 17, 2024 | +69.1% | +64.4% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: PATN vs SPY
From Sep 17, 2024: PATN grew to $16,913, SPY to $13,851.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
PATN returns by calendar year
1 of 1 full years positive. Best 2025 (+40.0%), worst 2025 (+40.0%). 2026 is year to date.
PATN annual returns table
| Year | PATN | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +22.9% | −14.4% | +12.3% | +15.1% | −1.0% |
| 2025 | +40.0% | −16.8% | +17.7% | +20.8% | +7.2% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
PATN largest drawdowns
Now 13.4% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Mar 19, 2025 | −16.8% | Apr 8, 2025 | May 19, 2025 | 20 days | 2 months |
| Feb 27, 2026 | −14.4% | Mar 30, 2026 | Apr 24, 2026 | 31 days | 56 days |
| Jun 22, 2026 | −14.1% | Jul 29, 2026 | not yet | 37 days | 4 months so far |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
PATN risk statistics
| Statistic | Since 2024 |
|---|---|
| Annualized return | +30.9% |
| Volatility (annualized) | 20.9% |
| Sharpe ratio | 1.21 |
| Sortino ratio | 2.26 |
| Best month | +14.2% |
| Worst month | −11.2% |
| Best 12 months | +71.1% |
| Worst 12 months | +21.1% |
| Positive months | 71% |
| Beta vs S&P 500 | — |
| Correlation with S&P 500 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
PATN rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 14 | +21.1% | +44.3% | +71.1% | 100% |
Every holding period starting at a month-end since 2024. Returns for 3 years and longer are annualized.
PATN performance overview
Pacer Nasdaq International Patent Leaders ETF (PATN) returned +24.5% over the past year, with distributions reinvested. Since its first recorded price on Sep 17, 2024 it has returned +69.1%. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −16.8%, from Mar 19, 2025 to Apr 8, 2025, and it took 41 days to get back to the old high. Volatility has been 20.9% a year.
Related: PATN chart, PATN holdings, PATN dividends. See the PATN overview for the latest quote and fund facts.
PATN performance FAQ
What is the PATN return over the past year?
PATN returned +24.5% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 21.7%.
How much would $10,000 invested in PATN be worth?
$10,000 invested in PATN at its first recorded close on September 17, 2024 would be worth about $16,913 on October 23, 2026 with distributions reinvested.
What is the biggest drawdown of PATN?
The largest peak-to-trough decline was −16.8% between March 19, 2025 and April 8, 2025. It recovered to the old high on May 19, 2025, 41 days after the bottom.
How volatile is PATN?
Over the past history PATN had an annualized volatility of 20.9% and a Sharpe ratio of 1.21 (excess return over 1–3 month T-bills per unit of risk).